Efficacy and safety of frozen-thawed embryo transfer in women aged 35 to 42 years from the PURSUE randomized clinical trial Robert Boostanfar, M.D., Davis Gates, Ph.D., Yanfen Guan, M.S., Keith Gordon, Ph.D., Christine McCrary Sisk, B.S., Barbara J. Stegmann, M.D. Fertility and Sterility Volume 106, Issue 2, Pages 300-305.e5 (August 2016) DOI: 10.1016/j.fertnstert.2016.03.041 Copyright © 2016 American Society for Reproductive Medicine Terms and Conditions
Figure 1 Cumulative vital pregnancy rate. CFA = corifollitropin alfa; rFSH = recombinant follicle-stimulating hormone. Fertility and Sterility 2016 106, 300-305.e5DOI: (10.1016/j.fertnstert.2016.03.041) Copyright © 2016 American Society for Reproductive Medicine Terms and Conditions
Figure 2 Cumulative live-birth rate. CFA = corifollitropin alfa; rFSH = recombinant follicle-stimulating hormone. Fertility and Sterility 2016 106, 300-305.e5DOI: (10.1016/j.fertnstert.2016.03.041) Copyright © 2016 American Society for Reproductive Medicine Terms and Conditions
Supplemental Figure 1 Women reaching pregnancy and live birth. CFA = corifollitropin alfa; FTET = frozen-thawed embryo transfer; rFSH = recombinant follicle-stimulating hormone. Fertility and Sterility 2016 106, 300-305.e5DOI: (10.1016/j.fertnstert.2016.03.041) Copyright © 2016 American Society for Reproductive Medicine Terms and Conditions
Supplemental Figure 2 Vital pregnancy rates (per cycle) in the PURSUE and FTET follow-up studies. CFA = corifollitropin alfa; FTET = frozen-thawed embryo transfer; rFSH = recombinant follicle-stimulating hormone. Fertility and Sterility 2016 106, 300-305.e5DOI: (10.1016/j.fertnstert.2016.03.041) Copyright © 2016 American Society for Reproductive Medicine Terms and Conditions